Focal therapy for prostate cancer-ready to be a standard of care?

Affiliations

¹ Department of Urology, Singapore General Hospital, SingHealth Duke-NUS Academic Medical Center, Academia, Singapore, Singapore. tay.kae.jack@singhealth.com.sg.

Editorial

Kae Jack Tay. Prostate Cancer Prostatic Dis. 2021 Dec.

. 2021 Dec;24(4):931-932.

doi: 10.1038/s41391-021-00376-7. Epub 2021 May 18.

¹ Department of Urology, Singapore General Hospital, SingHealth Duke-NUS Academic Medical Center, Academia, Singapore, Singapore. tay.kae.jack@singhealth.com.sg.

No abstract available

Comment on

Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
van Son MJ, Peters M, Reddy D, Shah TT, Hosking-Jervis F, Robinson S, Lagendijk JJW, Mangar S, Dudderidge T, McCracken S, Hindley RG, Emara A, Nigam R, Persad R, Virdi J, Lewi H, Moore C, Orczyk C, Emberton M, Arya M, Ahmed HU, van der Voort van Zyp JRN, Winkler M, Falconer A. van Son MJ, et al. Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1120-1128. doi: 10.1038/s41391-021-00369-6. Epub 2021 May 1. Prostate Cancer Prostatic Dis. 2021. PMID: 33934114

1. Tay KJ, Polascik T, Elshafei A, Tsivian E, Jones JS. Propensity score matched comparison of partial to whole gland cryotherapy for intermediate-risk prostate cancer: an analysis of the cold registry data. J Urol. 2016;195:e199. - DOI
1. Scheltema MJ, Chang JI, Bohm M, van den Bos W, Blazevski A, Gielchinsky I, et al. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy. World J Urol. 2018;36:1383–9.
1. Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-yr follow-up of the European randomized study of screening for prostate cancer. Eur Urol. 2019;76:43–51. - DOI
1. Wilt TJ, Vo TN, Langsetmo L, Dahm P, Wheeler T, Aronson WJ, et al. Radical prostatectomy or observation for clinically localized prostate cancer: extended follow-up of the prostate cancer intervention versus observation trial (PIVOT). Eur Urol. 2020;77:713–24. - DOI
1. von Hardenberg J, Borkowetz A, Siegel F, Kornienko K, Westhoff N, Jordan TB, et al. Potential candidates for focal therapy in prostate cancer in the era of magnetic resonance imaging–targeted biopsy: a large multicenter cohort study. European Urology Focus. 2020;S2405-4569:30274–1.